# Long-Term Prognostic Value of AFP and PIVKA-II in HCC After Living Donor Liver Transplantation: A Single-Center Retrospective Study

**Authors:** Saran Ochir Gongor, YoungRok Choi, Gayoung Kim, Min Kyoung Kim, Sang Hyuk Park, Jiyoung Kim, Jae-Yoon Kim, Su young Hong, Jeong-Moo Lee, Suk Kyun Hong, Kwang-Woong Lee

PMC · DOI: 10.3389/ti.2025.14748 · Transplant International · 2025-06-27

## TL;DR

This study compares the usefulness of tumor biomarkers AFP and PIVKA-II with other models in predicting outcomes for liver transplant patients with hepatocellular carcinoma.

## Contribution

The study evaluates the long-term prognostic value of AFP and PIVKA-II in HCC patients post-liver transplant compared to six existing models.

## Key findings

- AFP and PIVKA-II achieved iAUCs of 0.68–0.75 for recurrence and C-indices of 0.66–0.77 for mortality.
- Combining AFP and PIVKA-II improved performance with iAUCs up to 0.78 and C-indices up to 0.80.
- The R3-AFP model showed the most consistent performance with iAUC 0.76–0.81 and C-index 0.78–0.82.

## Abstract

Despite the development of numerous prognostic models for hepatocellular carcinoma (HCC) recurrence and mortality after liver transplantation, tumor biomarkers such as alpha-fetoprotein (AFP) and protein induced by vitamin K absence-II (PIVKA-II) remain widely used in clinical practice. This study evaluated the performance of AFP and PIVKA-II compared with six prognostic models (RETREAT, SNAPP, MoRAL, R3-AFP, METROTICKET 2.0, and SALT) in a retrospective cohort of 707 adults who underwent living donor liver transplantation (LDLT) for HCC between 2003 and 2018. Patients were stratified into Milan and Beyond Milan groups. Time-dependent receiver operating characteristic curve analysis was conducted using integrated area under the curve (iAUC) and concordance index (C-index) to assess recurrence and mortality. AFP and PIVKA-II (continuous) achieved iAUCs of 0.68–0.75 for recurrence and C-indices of 0.66–0.77 for mortality. Their combination reached iAUCs up to 0.78 and C-indices up to 0.80. Threshold models (AFP ≥200, PIVKA-II ≥400) showed modest predictive performance. Among multivariable models, R3-AFP demonstrated the most consistent performance (iAUC 0.76–0.81; C-index 0.78–0.82). SNAPP, MoRAL, and SALT also performed well. AFP and PIVKA-II may offer practical utility in resource-limited settings. However, multivariable models remain the preferred approach where comprehensive diagnostics are available.

## Linked entities

- **Diseases:** hepatocellular carcinoma (MONDO:0007256)

## Full-text entities

- **Genes:** AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}
- **Diseases:** tumor (MESH:D009369), HCC (MESH:D006528)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12245734/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12245734/full.md

## References

52 references — full list in the complete paper: https://tomesphere.com/paper/PMC12245734/full.md

---
Source: https://tomesphere.com/paper/PMC12245734